AstraZeneca chases Acerta to secure next cancer drug winner

LONDON (Reuters) - AstraZeneca said on Monday it was in talks that might lead to the acquisition of privately held biotech firm Acerta Pharma, a potential $5 billion-plus deal designed to build up its cancer drug portfolio.

http://ift.tt/1Orp3SE

from Reuters: Health News
via animenewspro